Moderna Aktie
WKN DE: A2N9D9 / ISIN: US60770K1079
|
02.07.2024 16:57:05
|
Moderna Awarded $176 Mln To Develop MRNA Influenza Vaccines
(RTTNews) - Moderna, Inc. (MRNA) announced on Tuesday that it has been awarded a $176 million project grant through the Rapid Response Partnership Vehicle, funded by BARDA within the U.S. Department of Health and Human Services to expedite the development of mRNA-based pandemic influenza vaccines.
The company said that this funding will support the advanced stages of development for an mRNA-based vaccine intended for the licensure of a pre-pandemic vaccine targeting the H5 influenza virus, which is known to cause a highly contagious and severe disease in birds and poses a potential risk of transmission to humans.
The agreement also includes provisions for preparing and expediting responses to future public health crises.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Moderna Incmehr Nachrichten
|
23.12.25 |
Pluszeichen in New York: S&P 500 letztendlich in Grün (finanzen.at) | |
|
23.12.25 |
Freundlicher Handel: So performt der S&P 500 am Nachmittag (finanzen.at) | |
|
23.12.25 |
Zuversicht in New York: S&P 500 verbucht am Dienstagmittag Gewinne (finanzen.at) | |
|
22.12.25 |
Zuversicht in New York: S&P 500 am Montagnachmittag freundlich (finanzen.at) | |
|
22.12.25 |
Gewinne in New York: Anleger lassen S&P 500 am Mittag steigen (finanzen.at) | |
|
19.12.25 |
S&P 500-Handel aktuell: S&P 500 klettert zum Ende des Freitagshandels (finanzen.at) | |
|
19.12.25 |
Starker Wochentag in New York: So steht der S&P 500 aktuell (finanzen.at) | |
|
19.12.25 |
Zuversicht in New York: mittags Pluszeichen im S&P 500 (finanzen.at) |
Analysen zu Moderna Incmehr Analysen
| 19.11.24 | Moderna Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.09.24 | Moderna Underweight | JP Morgan Chase & Co. | |
| 05.08.24 | Moderna Sector Perform | RBC Capital Markets | |
| 12.01.24 | Moderna Outperform | RBC Capital Markets |
Aktien in diesem Artikel
| Moderna Inc | 28,97 | -3,27% |
|